Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reductive Amination . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108395408B details a scalable route for [4-(1,1-difluoro-ethyl)-pyrimidine]-5-methanamine. Achieve cost reduction in API manufacturing with this efficient aqueous reduction strategy.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN106883238B reveals a high-yield 4-step route for alpha-azaspiro compounds, offering significant cost reduction and safety improvements for API intermediate manufacturing.
Patent CN103497202A details a safer reduction method for dorzolamide intermediates, eliminating toxic boranes and improving yield for reliable supply.
Patent CN103145562A details a safe, ambient-pressure route for N-ethylaniline using acetaldehyde, offering superior purity and cost efficiency for fine chemical manufacturing.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113185478B reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and significant cost reduction for pharmaceutical manufacturing.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.
Patent CN107001250A reveals a novel reduction method for Odanacatib intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Novel synthesis of belotecan hydrochloride via tryptamine. High yield, low cost, scalable for pharmaceutical intermediates supply chain.
Novel titanate-catalyzed route for high-purity deuterated standards. Enhances supply chain stability and reduces forensic analysis costs significantly for global labs.
Patent CN108864177A reveals a safer synthesis route for deuterated standards, offering significant supply chain stability and cost reduction opportunities for forensic laboratories.
Patent CN114907300B details a cost-effective route for Tazemetostat intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Novel synthesis route for Emedastine intermediate ensures >99% purity. Cost-effective manufacturing solution for reliable pharmaceutical intermediate supply chain partners.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Novel patent CN115466214B offers safer route for Valicarb intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.